{
    "patient": {
        "Name": "Jennifer Houston",
        "DateOfBirth": "1996-08-11",
        "Sex": "Female",
        "Diagnosis": "Chronic myeloid leukemia (CML)",
        "BodyPart": "Leukemia",
        "Physician": "Dr. Christopher Reynolds",
        "TreatingInstitution": "White, Jones and Carlson"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Leukemia",
            "CollectedDate": "2024-03-08",
            "ReceivedDate": "2024-03-14",
            "TumorPercentage": "50%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2024-03-12",
            "ReceivedDate": "2024-03-12"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Stopgain-LOF",
                "VariantAlleleFraction": "5.87%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1154_1155insTTGTC",
                "GeneMutation": "p.L367fs*46 Spliceregionvariant-LOF",
                "VariantAlleleFraction": "10.76%"
            },
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": " p.W266* Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "25.98%"
            },
            {
                "Gene": "CDC73",
                "DNA Alteration": "c.1A>G",
                "GeneMutation": " p.W266* Stopgain-LOF",
                "VariantAlleleFraction": "17.65%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "PTCH1",
            "PDGFRB",
            "SF3B1",
            "CALR"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "41 m/Mb",
            "Tmbpercentile": "23%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    },
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "SRSF2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.P95X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "21.92%"
            },
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.58%"
            },
            {
                "Gene": "CDC73",
                "DNA Alteration": "c.1A>G",
                "GeneMutation": "p.M1V Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "2.18%"
            },
            {
                "Gene": "PDGFRB",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.T681I Frameshift-LOF",
                "VariantAlleleFraction": "3.56%"
            },
            {
                "Gene": "IDH1",
                "DNA Alteration": "c.356G>A",
                "GeneMutation": "p.R132X Nonsense-LOF",
                "VariantAlleleFraction": "7.26%"
            },
            {
                "Gene": "JAK3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.L857P Nonsense-LOF",
                "VariantAlleleFraction": "2.48%"
            }
        ],
        "Germline": [
            {
                "Gene": "GNAS",
                "DNA Alteration": "c.679C>G",
                "GeneMutation": "p.Q227R Spliceregionvariant-LOF",
                "Condition": "report"
            }
        ]
    },
    "low coverage regions": [
        "ERCC2",
        "IDH1"
    ],
    "genomic variants details": {
        "Somatic Variant Details - Potentially Actionable": [
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Stopgain-LOF",
                "description": "ARID2 encodes a protein that is a subunit of the SWI/SNF chromatin remodeling complex SWI/SNF-B or PBAF. This complex functions in ligand-dependent transcriptional activation. Loss of function mutations and copy number loss of ARID2 are associated with cancer progression.",
                "VariantAlleleFraction": "5.87%"
            }
        ],
        "Somatic Variant Details - Biologically Relevant": [
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1154_1155insTTGTC",
                "GeneMutation": "p.L367fs*46 Spliceregionvariant-LOF",
                "description": "PTEN encodes a phosphatase that acts as a tumor suppressor by negatively regulating the PI3K-AKT-mTOR pathway. Loss of function mutations, copy number loss, and underexpression of PTEN are associated with cancer progression.",
                "VariantAlleleFraction": "10.76%"
            },
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": " p.W266* Missensevariant(exon2)-GOF",
                "description": "PTEN encodes a phosphatase that acts as a tumor suppressor by negatively regulating the PI3K-AKT-mTOR pathway. Loss of function mutations, copy number loss, and underexpression of PTEN are associated with cancer progression.",
                "VariantAlleleFraction": "25.98%"
            },
            {
                "Gene": "CDC73",
                "DNA Alteration": "c.1A>G",
                "GeneMutation": " p.W266* Stopgain-LOF",
                "description": "STK11 (LKB1) encodes an enzyme in the serine/threonine kinase family that is responsible for maintaining energy metabolism and cellular polarization through the activation of AMP-activated protein kinase and other members of the AMPK family. The enzyme also acts as a tumor suppressor by regulating cell growth. Loss of function mutations, copy number loss, epigenetic variation, and underexpression of STK11 are associated with cancer progression.",
                "VariantAlleleFraction": "17.65%"
            }
        ]
    },
    "clinical history": {
        "Date": "2024-03-07"
    },
    "other": {
        "ReportId": "9048",
        "ReportDate": "2024-03-10",
        "SignedBy": "Christopher Reynolds",
        "Supervisor": "Dr. Allison Owens"
    }
}